The investment seeks to track the S&P Global 1200 Health Care Sector IndexTM. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index. The index measures the performance of companies that the index provider deems to be a part of the healthcare sector of the economy and that the index provider believes are important to global markets.
Inception Date: 13/11/2001
Primary Benchmark: S&P Global 1200 Healthcare Sector NR USD
Primary Index: MSCI ACWI NR USD
Gross Expense Ratio: 0.47%
Management Expense Ratio: 0.48 %
|XLV||SPDR Select Sector Fund - Heal..||0.14 %||
|VHT||Vanguard Health Care||0.10 %||
|XBI||SPDR Series Trust S&P Biotech||0.35 %||
|IYH||iShares U.S. Healthcare||0.44 %||
|IHI||iShares U.S. Medical Devices||0.44 %||
|FBT||First Trust Amex Biotech Index..||0.56 %||
|FXH||First Trust Health Care AlphaD..||0.62 %||
|HQH||Tekla Healthcare Investors||0.00 %||
|FHLC||Fidelity MSCI Health Care Inde..||0.08 %||
|THQ||Tekla Healthcare Opportunies F..||0.00 %||
|Market Performance vs.
|Market Performance vs. Exchange (NYSE Arca)|
|Value||Sector Median||Percentile Rank||Grade||Market Median||Percentile Rank||Grade|
|Trailing 12 Months|
|Trailing 5 Years|
|Average Annual (5 Year Horizon)|
|Risk Return Profile|
|Volatility (Standard Deviation)||12.11%||79%||C+||61%||D-|
|Risk Adjusted Return||90.48%||71%||C-||73%||C|
|Target Price Action||Rating Action||Analyst||Rating||Price||Date|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.